World Health Organization

Innovation in the Age of Coronavirus

The COVID-19 pandemic and its evolving aftermath are reshaping the world around us, and myriad Long Island forces – large and small, corporate and nonprofit, industrial and academic – have risen to the challenge. Innovate Long Island presents Innovation in the Age of Coronavirus as a real-time journal of this region’s resourceful response to the greatest global challenge since World War II. Stay healthy, dear readers.   Arrow Exterminating donation extremely on-point (June 3) All…


LI institutions on call as nursing shortage spirals

By GREGORY ZELLER // With a national nursing shortage in their sights, Hofstra University and Northwell Health are launching a new undergraduate nursing program on Long Island – and planning a $60 million learning center to house it. The people who brought you the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra/Northwell School of Nursing and Physician Assistant Studies on Monday announced a new Bachelor of Science in Nursing program, with…


Applied DNA to speed up coronavirus countermeasures

By GREGORY ZELLER // Look out, coronavirus – Applied DNA is coming for you. Adding to its growing portfolio of cutting-edge Polymerase Chain Reaction-based projects, Stony Brook-based Applied DNA Sciences is expanding its Joint Development Agreement with Italian R&D company Takis Biotech, with the headline-making 2019-nCoV in their sights. Already hot on the trail of new cancer vaccines, the partners will now work on a “linear DNA” vaccine against the dreaded Wuhan, China-based illness that’s…


Coronavirus and you: How to survive the bugocalypse

By ANTHONY SANTELLA // The deadly coronavirus that originated 7,500 miles away in China may have found its way to Long Island, where health officials announced last week that a person who passed through Nassau County was being tested for the virus. That individual has since tested negative – but results are still pending for more than 100 other cases across the United States While the majority of the more than 2,700 global cases, including…


With synthetic opioids lurking, DNA detector scores

By GREGORY ZELLER // With synthetic opioids increasingly implicated in the alarming number of drug-overdose deaths plaguing the nation, a stalwart Long Island biotech’s DNA-based tracking technology has received a major endorsement. The peer-reviewed scientific journal PLOS ONE has published a paper by Stony Brook-based Applied DNA Sciences on the molecular tagging of pharmaceuticals – a next-gen supply-chain authenticator that Applied DNA considers unforgeable, inescapable and particularly useful in a world where counterfeit drugs are…


Chembio’s dengue field test earns Brazilian nod

By GREGORY ZELLER // Add another critical Brazilian regulatory approval to Chembio Diagnostics’ portfolio. The Medford-based point-of-care diagnostics specialist announced this its week the Agência Nacional de Vigilância Sanitária, Brazil’s federal health-regulatory agency, has approved Chembio’s DPP Dengue System. The test allows “simultaneous and discrete” detection of antibodies against all four dengue serotypes, covering both active infection by dengue virus and prior exposure to the virus – critical measures for both treatment and surveillance of…


Alessi: LI must work together on a 5G future

By MARC ALESSI // It’s no secret that Long Island has problems with cellphone service. More than 200 cellphone “dead zones” were identified in late 2016, as well as poor-quality network speed, reliability and performance. U.S. Senator Chuck Schumer (D-NY) has even urged carriers to improve coverage on the Island. As a longtime resident of the North Shore, I have witnessed firsthand what it means to not have reliable wireless connectivity with our mobile-enabled electronics….


Long-lasting glaucoma fix? They can see it from here

By GREGORY ZELLER // A Stony Brook biotech looking to carve a nanotech niche in the science of glaucoma treatment is eyeing some impressive laboratory results. Sustained Nano Systems, working closely with Stony Brook University’s Center for Biotechnology, has “achieved positive in-vitro results on long-term sustained delivery of Latanaprost for glaucoma treatment,” according to a company statement. Decoded: The biotech can keep the No. 1 glaucoma drug ticking for 159 days in in-vitro tests, which…


No. 267: On good fellows, spoon benders, Octomoms and trends to come

Welcome, dear readers: And over the year’s penultimate hump we go. Just five more days until Christmas and 11 until tumultuous 2017 runs its course. Boy, have you earned a holiday. The Innovate LI team will be catching up on baking, last-minute shopping and gift-wrapping, so watch for our next newsletter on Dec. 27. We hope you enjoy a peaceful, safe and joyous weekend! Before there was Octomom: When Nadya Suleman famously gave birth to…


NIH grant links LI researcher to top diabetes study

By GREGORY ZELLER // A multiyear federal grant will plug a top Long Island researcher into medical science’s foremost diabetes study. Alan Jacobson, chief research officer at Mineola-based NYU Winthrop Hospital, has secured a $4.23 million stipend from the National Institutes of Health to study the long-term neurocognitive effects of type 1 diabetes. The five-year grant will help Jacobson better understand how the disease – which affects more than 1.25 million Americans, according to the…